Literature DB >> 25252137

Risk factors associated with human Rift Valley fever infection: systematic review and meta-analysis.

Dennis E Nicholas1, Kathryn H Jacobsen, Nigel M Waters.   

Abstract

OBJECTIVE: To identify risk factors for human Rift Valley fever virus (RVFV) infection.
METHODS: A systematic review identified 17 articles reporting on 16 studies examining risk factors for RVFV. Pooled odds ratios (pOR) were calculated for exposures examined in four or more studies.
RESULTS: Being male [pOR = 1.4 (1.0, 1.8)], contact with aborted animal tissue [pOR = 3.4 (1.6, 7.3)], birthing an animal [pOR = 3.2 (2.4, 4.2)], skinning an animal [pOR = 2.5 (1.9, 3.2)], slaughtering an animal [pOR = 2.4 (1.4, 4.1)] and drinking raw milk [pOR = 1.8 (1.2, 2.6)] were significantly associated with RVF infection after meta-analysis. Other potential risk factors include sheltering animals in the home and milking an animal, which may both involve contact with animal body fluids.
CONCLUSIONS: Based on the identified risk factors, use of personal protective equipment and disinfectants by animal handlers may help reduce RVFV transmission during outbreaks. Milk pasteurisation and other possible preventive methods require further investigation.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Fiebre del Valle de Rift; Rift Valley fever; facteurs de risque; factores de riesgo; fièvre de la Vallée du Rift; meta-analysis; revisión sistemática; meta-análisis; revue systématique; méta-analyse; risk factors; systematic review

Mesh:

Year:  2014        PMID: 25252137     DOI: 10.1111/tmi.12385

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  30 in total

1.  Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.

Authors:  Aaron W Walters; Michael R Kujawa; Joseph R Albe; Douglas S Reed; William B Klimstra; Amy L Hartman
Journal:  Virology       Date:  2018-11-02       Impact factor: 3.616

2.  Adaptation to a Multiplex Bead Assay and Seroprevalence to Rift Valley Fever N Protein: Nampula Province, Mozambique, 2013-2014.

Authors:  Eric Rogier; Mateusz Plucinski; Baltazar Candrinho; Delynn M Moss; Aridth Gibbons; James Colborn; Jeffrey Higgins; Geraldo Chambe; Joao Muchanga; Olinda Muguande; Graca Matsinhe; Guidion Mathe; Timothy Doyle; Rose Zulliger; Abu Saifodine; Joel M Montgomery; John D Klena; Jeffrey W Priest
Journal:  J Virol       Date:  2022-07-27       Impact factor: 6.549

3.  A Cross-Sectional, Population-Based, Seroepidemiological Study of Rift Valley Fever in Cameroonian Cattle Populations.

Authors:  Barend Mark Bronsvoort; Robert Francis Kelly; Emily Freeman; Rebecca Callaby; Jean Marc Bagninbom; Lucy Ndip; Ian Graham Handel; Vincent Ngwang Tanya; Kenton Lloyd Morgan; Victor Ngu Ngwa; Gianluigi Rossi; Charles K Nfon; Stella Mazeri
Journal:  Front Vet Sci       Date:  2022-06-14

4.  Rift Valley fever virus detection in susceptible hosts with special emphasis in insects.

Authors:  K M Gregor; L M Michaely; B Gutjahr; M Rissmann; M Keller; S Dornbusch; F Naccache; K Schön; S Jansen; A Heitmann; R König; B Brennan; R M Elliott; S Becker; M Eiden; I Spitzbarth; W Baumgärtner; C Puff; R Ulrich; M H Groschup
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

5.  Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate.

Authors:  Devin A Boyles; Madeline M Schwarz; Joseph R Albe; Cynthia M McMillen; Katherine J O'Malley; Douglas S Reed; Amy L Hartman
Journal:  J Gen Virol       Date:  2021-02       Impact factor: 3.891

Review 6.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

7.  Integrated Analysis of Environment, Cattle and Human Serological Data: Risks and Mechanisms of Transmission of Rift Valley Fever in Madagascar.

Authors:  Marie-Marie Olive; Véronique Chevalier; Vladimir Grosbois; Annelise Tran; Soa-Fy Andriamandimby; Benoit Durand; Jean-Pierre Ravalohery; Seta Andriamamonjy; Fanjasoa Rakotomanana; Christophe Rogier; Jean-Michel Heraud
Journal:  PLoS Negl Trop Dis       Date:  2016-07-14

8.  Development and Assessment of a Geographic Knowledge-Based Model for Mapping Suitable Areas for Rift Valley Fever Transmission in Eastern Africa.

Authors:  Annelise Tran; Carlène Trevennec; Julius Lutwama; Joseph Sserugga; Marie Gély; Claudia Pittiglio; Julio Pinto; Véronique Chevalier
Journal:  PLoS Negl Trop Dis       Date:  2016-09-15

9.  Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.

Authors:  Ashwini Benedict; Neha Bansal; Svetlana Senina; Idris Hooper; Lindsay Lundberg; Cynthia de la Fuente; Aarthi Narayanan; Bradford Gutting; Kylene Kehn-Hall
Journal:  Front Microbiol       Date:  2015-07-08       Impact factor: 5.640

10.  A systematic review of Rift Valley Fever epidemiology 1931-2014.

Authors:  Mark O Nanyingi; Peninah Munyua; Stephen G Kiama; Gerald M Muchemi; Samuel M Thumbi; Austine O Bitek; Bernard Bett; Reese M Muriithi; M Kariuki Njenga
Journal:  Infect Ecol Epidemiol       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.